Inhibitor Therapeutics, Inc. (INTI): Operating Income
-$3.43M
Year ended 2025-12-31
-$3.37M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$3.43M | n/m | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | -$3.66M | n/m | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | -$3.40M | n/m | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | -$657.9K | n/m | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | -$325.4K | n/m | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | -$1.06M | n/m | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | -$2.75M | n/m | 2021-03-26, From 2019-01-01 |
| 2018-12-31 | -$4.56M | n/m | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | -$5.12M | n/m | 2019-03-07, From 2017-01-01 |
| 2016-12-31 | -$7.02M | n/m | 2018-02-16, From 2016-01-01 |
| 2015-12-31 | -$3.95M | n/m | 2017-02-17, From 2015-01-01 |
| 2014-12-31 | -$3.94M | n/m | 2016-02-01, From 2014-01-01 |
| 2013-12-31 | -$2.00M | n/m | 2015-02-13, From 2013-01-01 |
| 2012-12-31 | -$560.7K | n/a | 2014-04-15, From 2012-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Inhibitor Therapeutics, Inc. (INTI) | 2025-12-31 | -$3.43M | n/m |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | -$18.73M | n/m |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | -$5.08M | n/m |
| Artelo Biosciences, Inc. (ARTL) | 2025-12-31 | -$11.40M | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | -$6.59M | n/m |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$58.24M | n/m |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | -$3.08M | n/m |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | -$4.22M | n/m |
| Alzamend Neuro, Inc. (ALZN) | 2026-04-30 | -$8.77M | n/m |
Compare INTI, VCNX, LIPO, ARTL side by side · Screen every company in Pharmaceutical Preparations ↗